Penserra Capital Management LLC Sells 133 Shares of Molina Healthcare, Inc (NYSE:MOH)

Penserra Capital Management LLC trimmed its position in shares of Molina Healthcare, Inc (NYSE:MOH) by 31.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 284 shares of the company’s stock after selling 133 shares during the quarter. Penserra Capital Management LLC’s holdings in Molina Healthcare were worth $92,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Rothschild Investment LLC lifted its holdings in shares of Molina Healthcare by 126.3% during the 1st quarter. Rothschild Investment LLC now owns 86 shares of the company’s stock valued at $28,000 after buying an additional 48 shares during the period. Deseret Mutual Benefit Administrators lifted its holdings in shares of Molina Healthcare by 60.7% during the 1st quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company’s stock valued at $30,000 after buying an additional 34 shares during the period. Colonial Trust Co SC lifted its holdings in shares of Molina Healthcare by 930.0% during the 4th quarter. Colonial Trust Co SC now owns 103 shares of the company’s stock valued at $30,000 after buying an additional 93 shares during the period. Silver Oak Securities Incorporated bought a new position in shares of Molina Healthcare during the 1st quarter valued at $34,000. Finally, Hurley Capital LLC bought a new position in shares of Molina Healthcare during the 4th quarter valued at $55,000. 98.50% of the stock is owned by institutional investors.

Molina Healthcare Trading Down 3.3%

Shares of Molina Healthcare stock opened at $221.00 on Friday. The company has a market capitalization of $11.98 billion, a P/E ratio of 10.67, a P/E/G ratio of 0.93 and a beta of 0.55. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.63 and a current ratio of 1.63. The company has a fifty day moving average of $293.27 and a 200 day moving average of $303.29. Molina Healthcare, Inc has a fifty-two week low of $219.72 and a fifty-two week high of $365.23.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, beating the consensus estimate of $5.96 by $0.12. Molina Healthcare had a net margin of 2.81% and a return on equity of 28.38%. The business had revenue of $11.15 billion during the quarter, compared to the consensus estimate of $10.86 billion. During the same quarter in the prior year, the firm earned $5.73 EPS. The business’s revenue was up 12.2% on a year-over-year basis. On average, sell-side analysts anticipate that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.

Insider Activity

In other Molina Healthcare news, CEO Joseph M. Zubretsky sold 87,500 shares of the stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the completion of the transaction, the chief executive officer owned 257,715 shares of the company’s stock, valued at $82,484,262.90. This represents a 25.35% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Richard M. Schapiro sold 669 shares of the stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total transaction of $214,414.50. Following the transaction, the director directly owned 11,244 shares of the company’s stock, valued at $3,603,702. This trade represents a 5.62% decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research firms have recently commented on MOH. Baird R W lowered Molina Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 15th. Robert W. Baird restated a “neutral” rating and issued a $375.00 price objective (up from $331.00) on shares of Molina Healthcare in a research note on Tuesday, April 15th. Truist Financial upped their price objective on Molina Healthcare from $340.00 to $400.00 and gave the stock a “buy” rating in a research note on Friday, April 11th. Wall Street Zen lowered Molina Healthcare from a “buy” rating to a “hold” rating in a research note on Sunday, June 29th. Finally, Sanford C. Bernstein began coverage on Molina Healthcare in a research note on Tuesday, April 22nd. They issued an “outperform” rating and a $414.00 price objective for the company. Eleven analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $352.21.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.